BCAX Stock Price
Bicara Therapeutics Inc. Common Stock
BCAX stock price is $16.78 (-4.77% on the day), giving Bicara Therapeutics Inc. Common Stock a market cap of $1.11B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
BCAX Stock Overview
- Price
- $16.78
- Previous close
- $17.62
- Open
- $17.60
- Market cap
- $1.11B
- P/E ratio
- -8.0
- 52-week range
- $13.70 - $30.99
- 1-year price target
- $34.62
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 33
About Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. The company's lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $16.78 | -4.8% | 820.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW